申请人:The Governors of the University of Alberta
公开号:EP0239186A1
公开(公告)日:1987-09-30
Pharmaceutical compounds of the general formula (1):
have been prepared and non-toxic pharmaceutically acceptable salts thereof, wherein the ring system is a 1,2- or 1,4-dihydropyridyl radical; R1 is a hydrogen, lower alkyl, lower alkyl carbonyl or lower alkoxy carbonyl substituent; R2 is a lower alkyl or phenyl substituent; R3 is a lower alkoxy carbonyl, (N,N-lower dialkylamino) lower alkoxy carbonyl, (N-loweralkyl-N-phenyl lower alkyl amino) lower alkoxy carbonyl, lower alkoxy lower alkoxy carbonyl, nitro or cyano substituent; R4 is a member selected from the group consisting of pyridyl, N-lower alkoxy carbonyl-1,2-dihydropyridyl, N-lower alkyl carbonyl-1,2-dihydropyridyl, N-phenyloxy carbonyl-1,2-dihydropyridyl, N-lower alkoxy carbonyl-1,6-dihydropyridyl, N-lower alkyl carbonyl-1,6-dihydropyridyl, N-lower alkyl carbonyl-1,6-dihydropyridyl, N-phenyloxy carbonyl-1,6-dihydropyridyl, N-lower alkoxy carbonyl-1,4-dihydropyridyl, N-lower alkyl carbonyl-1,4-dihydropyridyl, N-phenyloxy carbonyl-1,4-dihydropyridyl, N-lower alkyl 1,2,3,6-tetrahydropyridyl, N-lower alkoxy carbonyl-1,2,3,6-tetrahydropyridyl, N-lower alkyl carbonyl-1,2,3,6-tetrahydropyridyl, nitro substituted phenyl or trifluoromethyl substituted phenyl; Rs is a lower alkoxy carbonyl, (N,N-lowerdialkylamino) lower alkoxycarbonyl, (N-loweralkyl-N-phenyl lower alkyl amino) lower alkoxy carbonyl, lower alkoxy lower alkoxy carbonyl, nitro, or cyano substitutent; R6 is a lower alkyl, or phenyl substituent, lower denoting a straight or branched chain having from 1-6 carbon atoms. The compounds exhibit antihypertensive activity due to their ability to induce cerebral and peripheral vasodilation, decrease heart rate, and/or increase cardiac contractility, and are useful in the treatment of angina, arrhythmias, cerebralvascular disease and hypertension.
通式(1)的药用化合物:
已制备出的药物化合物及其无毒的药学上可接受的盐,其中环系统是 1,2-或 1,4-二氢吡啶基;R1 是氢、低级烷基、低级烷基羰基或低级烷氧基羰基取代基;R2 是低级烷基或苯基取代基;R3 是低级烷氧基羰基、(N,N-低级二烷基氨基)低级烷氧基羰基、(N-低级烷基-N-苯基低级烷基氨基)低级烷氧基羰基、低级烷氧基低级烷氧基羰基、硝基或氰基取代基;R4 是选自吡啶基、N-低级烷氧基羰基-1,2-二氢吡啶基、N-低级烷基羰基-1,2-二氢吡啶基、N-苯基氧基羰基-1,2-二氢吡啶基、N-低级烷氧基羰基-1,6-二氢吡啶基、N-低级烷基羰基-1,6-二氢吡啶基、N-低级烷基羰基-1,6-二氢吡啶基、N-苯基氧基羰基-1、6-二氢吡啶基、N-低级烷氧基羰基-1,4-二氢吡啶基、N-低级烷基羰基-1,4-二氢吡啶基、N-苯氧基羰基-1,4-二氢吡啶基、N-低级烷基 1,2,3、1,2,3,6-四氢吡啶基、N-低级烷氧基羰基-1,2,3,6-四氢吡啶基、N-低级烷基羰基-1,2,3,6-四氢吡啶基、硝基取代的苯基或三氟甲基取代的苯基;Rs 是低级烷氧基羰基、(N,N-低级二烷基氨基)低级烷氧基羰基、(N-低级烷基-N-苯基低级烷基氨基)低级烷氧基羰基、低级烷氧基低级烷氧基羰基、硝基或氰基取代基;R6 是低级烷基或苯基取代基,低级表示具有 1-6 个碳原子的直链或支链。这些化合物具有抗高血压活性,因为它们能够诱导脑血管和外周血管扩张、降低心率和/或增加心脏收缩力,可用于治疗心绞痛、心律失常、脑血管疾病和高血压。